Timing of feeding tube may protect muscle in esophageal cancer patients
NCT ID NCT06712706
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines whether placing a feeding tube before chemotherapy helps prevent muscle loss in people with advanced esophageal cancer. About 60 adults receiving treatment with a goal to cure will be followed. Researchers will compare muscle mass at diagnosis, before surgery, and six months after surgery to see if early feeding tube placement makes a difference.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stadtspital Zürich
Zurich, 8063, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Could muscle loss predict stroke recovery?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Can nerve changes explain Age-Related muscle loss?
- Blood test score may flag High-Risk esophageal surgery patients
- Muscle loss in aging: can diet and exercise turn back the clock?